Sign in

    Julia Yue

    Research Analyst at JPMorgan Chase & Co.

    Julia Yue is an analyst at JPMorgan Chase & Co. with a research focus that includes companies such as Regencell Bioscience Holdings. According to research platforms, she has participated in at least one earnings call, reflecting her role in covering select firms within the biosciences space. While extensive performance metrics and prior career history are not publicly documented, her analyst contributions demonstrate engagement with industry-specific financial analysis. Julia Yue's broader credentials and registration status are not specified in available sources.

    Julia Yue's questions to Regencell Bioscience Holdings (RGC) leadership

    Julia Yue's questions to Regencell Bioscience Holdings (RGC) leadership • Q3 2017

    Question

    Julia Yue asked for more details on the upcoming ticket pricing test with Atom Tickets, including the number of markets and the timing, and whether the partnership has driven attendance or concession sales.

    Answer

    CEO Amy Miles explained the test will launch in Q1 2018 in a statistically significant number of markets to measure results against control markets. CFO David Ownby added that while they don't disclose partner-specific sales data, they see a significant impact in markets where partners like Atom engage in direct-to-consumer marketing.

    Ask Fintool Equity Research AI